Russia's proposed tobacco product regulation and licensing requirements

Apr.14.2023
Russia's proposed tobacco product regulation and licensing requirements
Russia proposes mandatory licenses for tobacco products and raw materials, effective from September 1, 2023.

On April 12th, the "Proposal on State Regulation of the Production and Circulation of Tobacco Products, Tobacco Industry Products, Nicotine-Containing Products and Their Raw Materials" (No. 310882-8, hereinafter referred to as "the Proposal") was passed in the first reading by the State Duma of Russia.


The following are the original text and Chinese translation of the relevant proposal by 2FIRSTS.


Classification of Mandatory Licensing Types


The first section of Article 8 of the proposal stipulates mandatory licensing requirements for the production and sale of tobacco products, nicotine-containing products, and raw materials used to produce such products.


What kinds of tobacco products are specifically covered by the license? Which stages require specific licenses? Is a license required for the import and export of products? Liang Jiasen, a market researcher for 2FIRSTS in Russia, provided a professional interpretation of the proposal.


According to the first part of Article 8 in general terms, activities related to the production and sale of tobacco products, nicotine-containing products, and materials utilized in the production of these products require a license.


The production, storage, and supply of tobacco products, raw materials, nicotine-containing products, and raw materials for the production, storage, and supply of tobacco products and nicotine-containing products are involved in their import and export within the Russian Federation. The circulation of raw materials and nicotine-containing raw materials is also included in their import and export within the Russian Federation. Additionally, the purchase of tobacco products and nicotine-containing products for use as duty-free trade under customs procedures, as well as the production, storage, and supply of cigars and related activities are included.


Experts Interpret


According to Liang Jiasen, a market researcher at 2FIRSTS, the first item on the license refers to a "raw material production license" for the production, storage, and supply of tobacco products, raw materials, nicotine-containing products, and nicotine raw materials. Such a license is required at every stage of the raw material production process.


Regarding the second provision on "production, storage and supply of tobacco products and products containing nicotine," this license is known as a "product manufacturing license," which is required for all stages of production for such products.


In relation to the third point regarding the circulation of tobacco and nicotine-containing products entering and exiting the Russian Federation, the license referred to is the "Product Import License". This license is necessary for the importation of such products into Russia and must be presented at all relevant stages of the process.


In relation to the fourth item on the import and export of raw materials and nicotine raw materials into and out of the Russian Federation, the license required is the "Raw Material Import License", which is necessary for the importation of such products into Russia. This license is required for all relevant import processes in Russia.


Regarding the fifth provision which pertains to the production, storage, and supply of cigars, it is identified as the "Cigar Production License" of the Russian Federation.


Regarding the sixth provision, which pertains to the purchase of tobacco and nicotine-containing products for sale as duty-free goods under customs procedures, this clause is part of the Russian Federation's "License for the Circulation of Duty-Free Tobacco and Nicotine products.


Scheduled to take effect on September 1st, 2023.


If the proposal is ultimately passed through the Russian legislative process, it will come into effect on September 1, 2023, with the mandatory licensing provisions outlined in Section 8, Part 1 of the proposal to be implemented on the same date. Holding a license will become a requirement from March 1, 2024. If tobacco manufacturers are found to not have a license, to have their license suspended or revoked, their production equipment will be ordered to be sealed.


2FIRSTS will continue to interpret and provide further details on laws and related content.


Topic: Progress and Expert Analysis on Russia's Ban on Flavored E-cigarettes (Click the Image Below to Jump)


Expert Analysis Series:


Expert analysis 1: The ban on flavored e-cigarettes in Russia includes all products, and the specific standards for additives have yet to be disclosed.


Expert analysis 2: Russia sets minimum retail price for e-cigarettes to reduce demand for nicotine products.


Further Reading:


Manufacturers of nicotine products in Russia now need to apply for a license following the approval of a draft law during its first reading.


Timeline and Background of Russia's Taste Ban Law Passed in Three Readings in One Day


On September 1st, a ban on flavor additives in e-cigarettes in Russia will take effect. The proposal text is available in reference 3. On April 11th, a proposal to ban flavored e-cigarettes in Russia will undergo its first discussion.


Russia proposes to impose a maximum fine of 500,000 rubles on those who sell electronic cigarettes to minors.


What is the progress in the ban on flavored products in the Russian legislative process?



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup’s 2026 Consumption Habits survey tracked nicotine pouch use for the first time. The survey found that 11% of U.S. adults reported smoking cigarettes in the past week, 9% reported vaping, and 4% reported using nicotine pouches. Cigarette smoking remained near Gallup’s long-term low, while adult vaping rates stayed relatively stable in recent years.
Market
Aug.25 by 2Firsts Perspectives
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
South Korean electronics component supplier ITM Semiconductor is reshaping its business portfolio after a decline in Apple-related protection circuit business, expanding its supply of vape devices and cartridges to KT&G. According to News1 on August 18, 2026, ITM’s vape-related revenue rose 24.8% year on year to 75.5 billion won in the first half of 2026. The company began mass production of vape devices at its Cikarang, Indonesia facility in January 2026, strengthening export manufacturing capacity. Meanwhile, Samsung-related protection circuit sales continued to grow, providing support during the transition.
Aug.20
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24